Author

Hesham Elghazaly

Professor of Clinical Oncology, Ain shams University - Cited by 2,506 - Breast cancer - GI cancer - Lung cancer

Biography

Hesham  Elghazaly worked at Ain Shams University , Clinical Oncology Department, Egypt. Subjects of Specialization: Breast cancer, GI cancer, Lung cancer, Cell Biology,Cell Culture,pathological Complete Response (pCR); Neoadjuvant chemotherapy; Dynamic MR-mammography.  
Title
Cited by
Year
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...The Lancet 400 (10352), 563-591, 2022202
157
2022
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ...Science 374 (6566), 423-431, 2021202
141
2021
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ...Science 378 (6615), eabq5358, 2022202
42
2022
Clinic-pathological pattern of hepatocellular carcinoma (HCC) in Egypt
H Elghazaly, A Gaballah, NB EldinAnnals of Oncology 29, v5-v6, 2018201
31
2018
Implementation of breast cancer continuum of care in low-and middle-income countries during the COVID-19 pandemic
H Elghazawy, J Bakkach, MS Zaghloul, A Abusanad, MM Hussein, ...Future Oncology 16 (31), 2551-2567, 2020202
23
2020
Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS …
SHA Agwa, MM Kamel, H Elghazaly, AM Abd Elsamee, H Hafez, ...Genes 12 (6), 830, 2021202
22
2021
Molecular variances between rectal and left-sided colon cancers.
J Marshall, HJ Lenz, J Xiu, WS El-Deiry, J Swensen, H El Ghazaly, ...Journal of Clinical Oncology 35 (4_suppl), 522-522, 2017201
16
2017
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers
MF Tolba, H Elghazaly, E Bousoik, MMA Elmazar, SM TolaneyClinical and Translational Oncology 23, 1979-1994, 2021202
16
2021
Characterization of tumor mutation burden (TMB) in gastrointestinal (GI) cancers.
ME Salem, J Xiu, BA Weinberg, WS El-Deiry, LM Weiner, Z Gatalica, Z Liu, ...Journal of Clinical Oncology 35 (4_suppl), 530-530, 2017201
14
2017
The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐and middle‐income countries and the MENA region
H Elghazaly, AT Aref, BO Anderson, B Arun, CH Yip, H Abdelaziz, ...International journal of cancer 149 (3), 505-513, 2021202
12
2021
ABHD4-regulating RNA panel: novel biomarkers in acute coronary syndrome diagnosis
SHA Agwa, SS Elzahwy, MS El Meteini, H Elghazaly, M Saad, ...Cells 10 (6), 1512, 2021202
11
2021
In silico identification and clinical validation of a novel long non-coding RNA/mRNA/miRNA molecular network for potential biomarkers for discriminating SARS CoV-2 infection …
SHA Agwa, H Elghazaly, MSE Meteini, SM Shawky, M Ali, ...Cells (11), 3098, 2021202
10
2021
Breast-gynaecological & immuno-oncology international cancer conference (BGICC) consensus and recommendations for the management of triple-negative breast cancer
H Elghazaly, HS Rugo, HA Azim, SM Swain, B Arun, M Aapro, EA Perez, ...Cancers 13 (), 2262, 2021202
9
2021
MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer
M Badr, H Said, ML Louka, HA Elghazaly, A Gaballah, ...Journal of Cellular Biochemistry 120 (3), 345-3466, 20120
9
2019
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women
C Corsini, S Henouda, DB Nejima, H Bertet, A Toledano, H Boussen, ...Breast cancer research and treatment 166, 631-639, 2017201
8
2017
Molecular characterization of squamous cell carcinoma of the anal canal (SCCA).
BA Weinberg, HJ Lenz, D Arguello, WS El-Deiry, J Xiu, Z Gatalica, Z Liu, ...Journal of Clinical Oncology 35 (_suppl), 538-538, 2017201
4
2017
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts
H Elghazaly, N Mottet, J Garcia, S Oudard, M Roach, C Abbou, ...World Journal of Urology 9, 1421-1429, 2021202
3
2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
YI Mohamed, S Lee, L Xiao, MM Hassan, A Qayyum, R Hiatia, ...Oncotarget 1 (8), 756, 010
2
2021
Employing 18F-FDG PET/CT for distinguishing benign from metastatic adrenal masses
R Refaat, H ElghazalyThe Egyptian Journal of Radiology and Nuclear Medicine 48 (4), 1065-1071, 01701
2
2017
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer–International considerations amongst upper …
JCH Goh, C Gourley, DSP Tan, A Nogueira-Rodrigues, H Elghazaly, ...Gynecologic Oncology Reports 42, 0028, 2022202
1
2022

Referred From: https://scholar.google.com.eg/citations?user=1N9yTIEAAAAJ&hl=en

Cited by
Citations 2506
h-index 13
i10-index 17
Recommended Journals
Open Access Journals